N Engl J Med 377:839848 Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR et al (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
Ross RS, Viazov S, Salloum S, Hilgard P, Gerken G, Roggendorf M (2010) Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification
Administering Melanotan-1 before bed minimizes daytime flushing, and starting at 0.08mg for 35 days before escalating to 0.160.20mg reduces incidence significantly
Huberman has also publicly discussed the difference between medications developed through regulated research and products obtained through questionable gray-market sources
A comparative study of the interaction of naringenin with lysozyme by multi-spectroscopic methods, activity comparisons, and molecular modeling procedures